Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 20 of 256

1.

The Role of Magnetic Resonance Imaging in Brachytherapy.

Tharmalingam H, Alonzi R, Hoskin PJ.

Clin Oncol (R Coll Radiol). 2018 Nov;30(11):728-736. doi: 10.1016/j.clon.2018.07.024. Epub 2018 Jul 31.

PMID:
30075902
2.

Outcomes of radiosensitisation in elderly patients with advanced bladder cancer.

Christodoulou M, Reeves KJ, Hodgson C, Zeniou A, Slevin F, Kennedy J, Hoskin PJ, Henry A, Choudhury A.

Radiother Oncol. 2018 Jun 2. pii: S0167-8140(18)30281-0. doi: 10.1016/j.radonc.2018.05.022. [Epub ahead of print]

PMID:
29871812
3.

Development and Validation of a 28-gene Hypoxia-related Prognostic Signature for Localized Prostate Cancer.

Yang L, Roberts D, Takhar M, Erho N, Bibby BAS, Thiruthaneeswaran N, Bhandari V, Cheng WC, Haider S, McCorry AMB, McArt D, Jain S, Alshalalfa M, Ross A, Schaffer E, Den RB, Jeffrey Karnes R, Klein E, Hoskin PJ, Freedland SJ, Lamb AD, Neal DE, Buffa FM, Bristow RG, Boutros PC, Davicioni E, Choudhury A, West CML.

EBioMedicine. 2018 May;31:182-189. doi: 10.1016/j.ebiom.2018.04.019. Epub 2018 Apr 23.

4.

Adjuvant chemoradiotherapy versus radiotherapy alone for women with high-risk endometrial cancer (PORTEC-3): final results of an international, open-label, multicentre, randomised, phase 3 trial.

de Boer SM, Powell ME, Mileshkin L, Katsaros D, Bessette P, Haie-Meder C, Ottevanger PB, Ledermann JA, Khaw P, Colombo A, Fyles A, Baron MH, Jürgenliemk-Schulz IM, Kitchener HC, Nijman HW, Wilson G, Brooks S, Carinelli S, Provencher D, Hanzen C, Lutgens LCHW, Smit VTHBM, Singh N, Do V, D'Amico R, Nout RA, Feeney A, Verhoeven-Adema KW, Putter H, Creutzberg CL; PORTEC study group.

Lancet Oncol. 2018 Mar;19(3):295-309. doi: 10.1016/S1470-2045(18)30079-2. Epub 2018 Feb 12. Erratum in: Lancet Oncol. 2018 Apr;19(4):e184.

5.

Bladder cancer and the National Cancer Data Base: New insight or misinformation?

Choudhury A, Hoskin PJ.

Cancer. 2018 Mar 15;124(6):1105-1107. doi: 10.1002/cncr.31210. Epub 2018 Jan 16. No abstract available.

PMID:
29338078
6.

Focal boost to residual gross tumor volume in brachytherapy for cervical cancer-A feasibility study.

Thiruthaneeswaran N, Groom N, Lowe G, Bryant L, Hoskin PJ.

Brachytherapy. 2018 Jan - Feb;17(1):181-186. doi: 10.1016/j.brachy.2017.09.012. Epub 2017 Nov 15.

PMID:
29153466
7.

The optimism surrounding stereotactic body radiation therapy and immunomodulation.

Tharmalingam H, Hoskin PJ.

Chin Clin Oncol. 2017 Sep;6(Suppl 2):S9. doi: 10.21037/cco.2017.05.01. Review.

8.

The evolution of brachytherapy for prostate cancer.

Zaorsky NG, Davis BJ, Nguyen PL, Showalter TN, Hoskin PJ, Yoshioka Y, Morton GC, Horwitz EM.

Nat Rev Urol. 2017 Jun 30;14(7):415-439. doi: 10.1038/nrurol.2017.76. Review.

PMID:
28664931
9.

Treat All Known Disease.

Hoskin PJ.

Int J Radiat Oncol Biol Phys. 2017 Jul 1;98(3):494. doi: 10.1016/j.ijrobp.2016.12.006. No abstract available.

PMID:
28581386
10.

Abiraterone for Prostate Cancer Not Previously Treated with Hormone Therapy.

James ND, de Bono JS, Spears MR, Clarke NW, Mason MD, Dearnaley DP, Ritchie AWS, Amos CL, Gilson C, Jones RJ, Matheson D, Millman R, Attard G, Chowdhury S, Cross WR, Gillessen S, Parker CC, Russell JM, Berthold DR, Brawley C, Adab F, Aung S, Birtle AJ, Bowen J, Brock S, Chakraborti P, Ferguson C, Gale J, Gray E, Hingorani M, Hoskin PJ, Lester JF, Malik ZI, McKinna F, McPhail N, Money-Kyrle J, O'Sullivan J, Parikh O, Protheroe A, Robinson A, Srihari NN, Thomas C, Wagstaff J, Wylie J, Zarkar A, Parmar MKB, Sydes MR; STAMPEDE Investigators.

N Engl J Med. 2017 Jul 27;377(4):338-351. doi: 10.1056/NEJMoa1702900. Epub 2017 Jun 3.

11.

A Gene Signature for Selecting Benefit from Hypoxia Modification of Radiotherapy for High-Risk Bladder Cancer Patients.

Yang L, Taylor J, Eustace A, Irlam JJ, Denley H, Hoskin PJ, Alsner J, Buffa FM, Harris AL, Choudhury A, West CML.

Clin Cancer Res. 2017 Aug 15;23(16):4761-4768. doi: 10.1158/1078-0432.CCR-17-0038. Epub 2017 Apr 11.

12.

The dosimetric impact of air in vaginal vault brachytherapy.

Maxwell Á, Thiruthaneeswaran N, Lowe G, Wills R, Sripali S, Hoskin PJ.

Brachytherapy. 2016 Nov - Dec;15(6):832-838. doi: 10.1016/j.brachy.2016.08.006. Epub 2016 Sep 29.

PMID:
27693171
13.

Expression of miR-210 in relation to other measures of hypoxia and prediction of benefit from hypoxia modification in patients with bladder cancer.

Irlam-Jones JJ, Eustace A, Denley H, Choudhury A, Harris AL, Hoskin PJ, West CM.

Br J Cancer. 2016 Aug 23;115(5):571-8. doi: 10.1038/bjc.2016.218. Epub 2016 Jul 21.

14.

High dose rate brachytherapy for prostate cancer: Standard of care and future direction.

Thiruthaneeswaran N, Hoskin PJ.

Cancer Radiother. 2016 Feb;20(1):66-72. doi: 10.1016/j.canrad.2016.01.001. Epub 2016 Jan 22. Review.

PMID:
26811209
15.

Dose-effect relationship and risk factors for vaginal stenosis after definitive radio(chemo)therapy with image-guided brachytherapy for locally advanced cervical cancer in the EMBRACE study.

Kirchheiner K, Nout RA, Lindegaard JC, Haie-Meder C, Mahantshetty U, Segedin B, Jürgenliemk-Schulz IM, Hoskin PJ, Rai B, Dörr W, Kirisits C, Bentzen SM, Pötter R, Tanderup K; EMBRACE Collaborative Group.

Radiother Oncol. 2016 Jan;118(1):160-6. doi: 10.1016/j.radonc.2015.12.025. Epub 2016 Jan 9.

PMID:
26780997
16.

Randomized Double-Blind Trial of Pregabalin Versus Placebo in Conjunction With Palliative Radiotherapy for Cancer-Induced Bone Pain.

Fallon M, Hoskin PJ, Colvin LA, Fleetwood-Walker SM, Adamson D, Byrne A, Murray GD, Laird BJ.

J Clin Oncol. 2016 Feb 20;34(6):550-6. doi: 10.1200/JCO.2015.63.8221. Epub 2015 Dec 7.

17.

A Delphi consensus study on salvage brachytherapy for prostate cancer relapse after radiotherapy, a Uro-GEC study.

Kaljouw E, Pieters BR, Kovács G, Hoskin PJ.

Radiother Oncol. 2016 Jan;118(1):122-30. doi: 10.1016/j.radonc.2015.10.021. Epub 2015 Nov 5.

PMID:
26549865
18.

Recommendations for Radiotherapy Technique and Dose in Extra-nodal Lymphoma.

Hoskin PJ, Díez P, Gallop-Evans E, Syndikus I, Bates A, Bayne M; Participants of the National Cancer Research Institute Lymphoma Radiotherapy Group.

Clin Oncol (R Coll Radiol). 2016 Jan;28(1):62-8. doi: 10.1016/j.clon.2015.09.005. Epub 2015 Oct 9.

PMID:
26456507
19.

Hypoxia dose painting in prostate and cervix cancer.

Hoskin PJ.

Acta Oncol. 2015;54(9):1259-62. doi: 10.3109/0284186X.2015.1061692. Epub 2015 Jul 6. Review. No abstract available.

PMID:
26148050
20.

Stereotactic body radiotherapy for spinal and bone metastases.

Bhattacharya IS, Hoskin PJ.

Clin Oncol (R Coll Radiol). 2015 May;27(5):298-306. doi: 10.1016/j.clon.2015.01.030. Epub 2015 Feb 14. Review.

PMID:
25687175

Supplemental Content

Loading ...
Support Center